Stem Cell Evidence
@evidencestemc
Followers
573
Following
488
Media
756
Statuses
2K
No longer posting in this account. Follow Stem Cell Evidence on other social media platforms Curating the evidence in haematopoietic stem cell transplantation.
Joined January 2017
The Stem Cell Evidence - December 2024, alert is out!. See the top 10 articles of the month and subscribe to this free email alert here: .
0
0
0
From the #StemCellEvidence Alert: . Optimal infused CD34+ cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation.by Pasvolsky et al.
0
0
1
New from #StemCellEvidence:. Utilization of hematopoietic cell transplantation and cellular therapy technology in Europe and associated Countries. Using the 2022 activity survey data to correlate with economic and demographic factors (. ).Passweg et al.
0
0
0
RT @NHSBT_RD: 🌟Big shout out to our colleagues over in CMT - this is incredible - what a start to the year! 🌟#nhsbtproud.
0
2
0
From the #StemCellEvidence Alert: . Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation (. ).by Ortà et al.
0
0
1
RT @NHSBTTAS: An exciting new post is available that offers the opportunity to become a Locum Consultant Haematologist with an interest in….
0
3
0
New from #StemCellEvidence:. Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxis.by Meyer et al.
0
1
1
From the #StemCellEvidence Alert: . Impact of cytopenias and early versus late treatment with ruxolitinib in patients with steroid-refractory acute or chronic graft-versus-host disease.by Mahmoudjafari et al.
0
2
4
New from #StemCellEvidence:. Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia.by Gui et al.
0
2
2
From the #StemCellEvidence Alert: . Quantifying HLA Mismatches at Epitope Level in Haplo-HSCT: Impact in the Outcome in Strategies Using PTCy.by Gil-Etayo et al.
0
0
0
New from #StemCellEvidence:. Itacitinib for Prevention of Graft-Versus-Host Disease and Cytokine Release Syndrome in Haploidentical Transplantation.by Abboud et al.
0
2
1
RT @TransfusionLib: New from the #Transfusion Evidence Round-Up: Best of the TEL 2024:. Two-year outcomes following a randomised platelet t….
0
1
0
RT @TransfusionLib: From the #Transfusion Evidence Round-Up: Best of the TEL 2024:. Prehospital #tranexamicacid is associated with a surviv….
0
4
0
RT @AnthonyNolan: 🚨PLEASE SHARE – Urgent search for donors 🚨. Natassa, aged 19, urgently needs a stem cell donor. In April she was diagnos….
0
322
0
RT @TransfusionLib: From the #Transfusion Evidence Round-Up: Best of the TEL 2024:. Andexanet for Factor Xa Inhibitor-Associated Acute Intr….
0
4
0
New from #StemCellEvidence:. Novel machine learning technique further clarifies unrelated donor selection to optimize transplantation outcomes.by Spellman et al.
0
0
1
From the #StemCellEvidence Alert:. Soluble MICA concentrations and genetic variability of MICA and its NKG2D receptor as factors affecting Graft-versus-Host Disease development after allogeneic haematopoietic stem cell transplantation.by Siemaszko et al.
0
0
1
RT @TransfusionLib: The #Transfusion Evidence Round-Up: Best of the TEL 2024 is out!. See all the top articles here:..
0
3
0
New from #StemCellEvidence:. Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myeloma.by Sidana et al.
0
0
1
From the #StemCellEvidence Alert: . Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial.by Russo et al.
0
1
1